Global Market Expansion The company's active participation in international events such as Medical Korea 2026 and the Global Health Exhibition in Riyadh indicates a focused effort on expanding its global reach, presenting opportunities to offer localized sales and support solutions tailored to diverse markets.

Affordable PCR Solutions With a mission to deliver high-quality, affordable PCR testing platforms, there is a strong opportunity to position cost-effective diagnostic kits and services to healthcare providers and governments seeking reliable infectious disease testing in remote or resource-limited areas.

Innovative Diagnostic Technology The proprietary Co-Primers™ technology and upcoming at-home PCR platform provide an attractive value proposition for labs and clinics aiming to upgrade their testing capacity with cutting-edge, accurate solutions that can be integrated into various healthcare settings.

Strategic Funding and Growth Recent financing of $7 million highlights ongoing efforts to scale operations and accelerate product deployment, indicating a receptive environment for partnerships, licensing agreements, or joint ventures to expand market presence.

Diverse Customer Segments Participation in industry conferences and trade shows across regions suggests a diverse client base, including hospital labs, governments, and research institutions, offering multiple avenues for tailored product offerings and service solutions to meet varied diagnostic needs.